Evidence map›Paper›PMID 23130995›Full record

ReviewClinical genetics2013

Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.

N Bögershausen, E Bruford, B Wollnik

Open access · hybridAbstract readReview
In one paragraph

Review in Clinical genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Neurobehavioral features in individuals with Kabuki syndrome.Molecular genetics & genomic medicine · 2018
    Article
  7. Targeting human SET1/MLL family of proteins.Protein science : a publication of the Protein Society · 2017
    Review
  8. RAP1-mediated MEK/ERK pathway defects in Kabuki syndrome.The Journal of clinical investigation · 2015
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

N BögershausenInstitute of Human Genetics, University of Cologne, Cologne, Germany.
E Bruford
B Wollnik
Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases · DEEuropean Bioinformatics Institute · GB

Funding

The Nomenclature of Human GenesP41HG003345 · NHGRI · UNIVERSITY COLLEGE LONDON · PI BIRNEY, EWAN · 2004 to 2012
$3.4M
NHGRI NIH HHS P41 HG003345
6 · The paper itself

Abstract

To unravel the system of epigenetic control of transcriptional regulation is a fascinating and important scientific pursuit. Surprisingly, recent successes in gene identification using high-throughput sequencing strategies showed that, despite their ubiquitous role in transcriptional control, dysfunction of chromatin-modifying enzymes can cause very specific human developmental phenotypes. An intriguing example is the identification of de novo dominant mutations in MLL2 as a cause of Kabuki syndrome, a well-known congenital syndrome that is associated with a very recognizable facial gestalt. However, the existing confusion in the nomenclature of the human and mouse MLL gene family impedes correct interpretation of scientific findings for these genes and their encoded proteins. This Review aims to point out this nomenclature pitfall, to explain its historical background, and to promote an unequivocal nomenclature system for chromatin-modifying enzymes as proposed by Allis et al. (2007).

Indexed as

Terminology as TopicAbnormalities, MultipleAnimalsDNA-Binding ProteinsFaceHematologic DiseasesHistone-Lysine N-MethyltransferaseHistonesHumansMutationNeoplasm ProteinsSyndromeVestibular DiseasesDNA-Binding ProteinsHistone-Lysine N-MethyltransferaseHistonesKMT2D protein, humanNeoplasm Proteins

Identifiers

PMID23130995
PMCPMC3597981
OpenAlexW1911077795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.